---
title: "博安生物自主开发药物度拉糖肽注射液获批上市"
description: "博安生物自主开发的博优平®（度拉糖肽注射液）已获得国家药品监督管理局的上市批准，主要用于成人 2 型糖尿病患者的血糖控制。该药物是一种长效 GLP-1 受体激动剂，商业化由博安生物与上药控股合作进行。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/252337903.md"
published_at: "2025-08-09T13:58:45.000Z"
---

# 博安生物自主开发药物度拉糖肽注射液获批上市

> 博安生物自主开发的博优平®（度拉糖肽注射液）已获得国家药品监督管理局的上市批准，主要用于成人 2 型糖尿病患者的血糖控制。该药物是一种长效 GLP-1 受体激动剂，商业化由博安生物与上药控股合作进行。

博安生物港交所公告，公司自主开发的博优平®（度拉糖肽注射液）已获得国家药品监督管理局的上市批准，用于成人 2 型糖尿病患者的血糖控制。博优平®是一种长效 GLP-1（胰高血糖素样肽-1）受体激动剂，其在中国大陆的商业化由公司与上药控股合作开展。

### Related Stocks

- [06955.HK - 博安生物](https://longbridge.com/zh-CN/quote/06955.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| UBTECH Robotics Calls March EGM to Approve 43% Stake in Zhejiang Fenglong Electric | UBTECH Robotics Corp Ltd has scheduled an extraordinary general meeting on March 10, 2026, in Shenzhen to seek sharehold | [Link](https://longbridge.com/zh-CN/news/276118745.md) |
| Novautek Technologies expects loss of HK$30.5 million for HY | Novautek Technologies expects loss of HK$30.5 million for HY | [Link](https://longbridge.com/zh-CN/news/275923659.md) |
| Madagascan cobalt producer Ambatovy's operations hit by cyclone, traders say | Madagascan cobalt producer Ambatovy's operations hit by cyclone, traders say | [Link](https://longbridge.com/zh-CN/news/275920460.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-CN/news/276051793.md) |
| Olympics-Figure skating-Malinin making history with skating's first Olympic backflip in decades | Ilia Malinin made history by landing the first legal Olympic backflip in figure skating since 1976 at the Milano Cortina | [Link](https://longbridge.com/zh-CN/news/275792466.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。